Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 18;10(6):1259.
doi: 10.3390/jcm10061259.

Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene

Affiliations

Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene

David Araújo-Vilar et al. J Clin Med. .

Abstract

Patients with Dunnigan disease (FPLD2) with a pathogenic variant affecting exon 8 of the LMNA gene are considered to have the classic disease, whereas those with variants in other exons manifest the "atypical" disease. The aim of this study was to investigate the degree of variable expressivity when comparing patients carrying the R482 and N466 variants in exon 8. Thus, 47 subjects with FPLD2 were studied: one group of 15 patients carrying the N466 variant and the other group of 32 patients with the R482 variant. Clinical, metabolic, and body composition data were compared between both groups. The thigh skinfold thickness was significantly decreased in the R482 group in comparison with the N466 group (4.2 ± 1.8 and 5.6 ± 2.0 mm, respectively, p = 0.002), with no other differences in body composition. Patients with the N466 variant showed higher triglyceride levels (177.5 [56-1937] vs. 130.0 [55-505] mg/dL, p = 0.029) and acute pancreatitis was only present in these subjects (20%). Other classic metabolic abnormalities related with the disease were present regardless of the pathogenic variant. Thus, although FPLD2 patients with the R482 and N466 variants share most of the classic characteristics, some phenotypic and metabolic differences suggest possible heterogeneity even within exon 8 of the LMNA gene.

Keywords: DXA; Dunnigan disease; LMNA; body composition; laminopathies; lipodystrophy; variable expressivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Garg A. Acquired and inherited lipodystrophies. N. Engl. J. Med. 2004;350:1220–1234. doi: 10.1056/NEJMra025261. - DOI - PubMed
    1. Garg A., Peshock R.M., Fleckenstein J.L. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety) J. Clin. Endocrinol. Metab. 1999;84:170–174. doi: 10.1210/jcem.84.1.5383. - DOI - PubMed
    1. Araújo-Vilar D., Santini F. Diagnosis and treatment of lipodystrophy: A step-by-step approach. J. Endocrinol. Invest. 2019;42:61–73. doi: 10.1007/s40618-018-0887-z. - DOI - PMC - PubMed
    1. Araújo-Vilar D., Loidi L., Domínguez F., Cabezas-Cerrato J. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm. Metab. Res. 2003;35:29–35. doi: 10.1055/s-2003-38388. - DOI - PubMed
    1. Vantyghem M.-C., Pigny P., Maurage C.A., Rouaix-Emery N., Stojkovic T., Cuisset J.M., Millaire A., Lascols O., Vermersch P., Wemeau J.L., et al. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J. Clin. Endocrinol. Metab. 2004;89:5337–5346. doi: 10.1210/jc.2003-031658. - DOI - PubMed

LinkOut - more resources